Hasan Jafri

Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ.

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Corthera, Inc. develops and manufactures pharmaceuticals, such as cardiovascular preparations. It engages in acquiring, developing, and commercializing therapies for illnesses in the acute care setting. The company was founded in 2003 and is headquartered in San Carlos, CA.

InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA.

Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD.

Flugen, Inc. develops and produces influenza vaccines. Its products include a live attenuated vaccine candidate, a cell-line technology that provides vaccine production efficiency and capacity, and a novel, vaccine-loaded intradermal delivery technology. The company was founded by Yoshihiro Kawaoka, Gabriele Neumann and Paul Radspinner in 2007 and is headquartered in Madison, WI.

Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.

Cygnus Solutions, Inc. develops software development platforms based on an open source model. The company was founded by Michael Tiemann, David Henkel-Wallace and John Gilmore and is headquartered in Sunnyvale, CA.

Unitron Medical Communications, Inc. operates as a research and media organization. The firm provides an online platform for the promotion of ideas, technologies, and companies in the health and medicine sector. It gives ability to connect and access information and resources to investors, entrepreneurs, executives, and scientists. The company was founded in 1991 and is headquartered in New York, NY.

Part of Graphics Properties Holdings, Inc., Mips Computer Systems, Inc. is a company that develops microprocessors. The company is based in Sunnyvale, CA. The company was founded by Chris Rowen, John LeRoy Hennessy. Mips Computer Systems was acquired by Silicon Graphics, Inc. on June 30, 1992 for $333.91 million.

Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA.

St. Jude Children's Research Hospital, Inc. offers health care and social assistance services for children. It is internationally recognized for its pioneering research and treatment for children with cancer and other catastrophic diseases. The firm's treatment programs include brain tumors, leukemia, lymphoma, infectious diseases, immunodeficiency diseases, blood disorders, sickle cell disease, and solid tumors. The company was founded by Danny Thomas on February 4, 1962 and is headquartered in Memphis, TN.

Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.

Point32Health, Inc. is a health and wellbeing organization that provides affordable and high-quality health care to its 2 million members. The non-profit company is based in Watertown, MA, and has subsidiaries in the United States. The company offers a diverse range of health plans that cater to the needs of its members, regardless of their age, race, ethnicity, socioeconomic status, orientation, gender identity, or ability. Point32Health is one of the top twenty health plans in the United States and builds on the quality of its founding organizations, Tufts Health Plan and Harvard Pilgrim Health Care. Cain A. Hayes has been the CEO of the company since 2021.

Longwood Fund Management LLC (Longwood Fund Management) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Dipp and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts.

The Abt Bio-Pharma Solutions team has provided integrated strategic, research, and communications services to the pharmaceutical, biotechnology, medical device, and diagnostics industries for 25 years. Its parent company, Abt Associates Inc., is one of the largest research and consulting firms in the world, applying scientific expertise to a wide range of health, economic, social, environmental, and technological policy issues. Founded in 1965, Abt Associates has annual revenue in excess of $200 million and a staff of more than 1,000, including national and international experts who are recognized for their knowledge, innovative research techniques, and insightful analysis & recommendations. In the early 1980s, Abt Associates' staff of bio statisticians, clinicians, health economists, and strategic consultants began designing, analyzing, and reporting on clinical trials for a broad variety of drugs and devices covering many therapeutic areas. Over the next decade, their services for commercial sponsors grew to include registries and other real world studies designed to evaluate safety, efficacy, economic, patient compliance, and health-related quality-of-life factors. The Abt Associates Clinical Trials (AACT) division was created in 1997, combining capabilities in bio-statistics, data management, epidemiology, and clinical trials management. To help sponsors demonstrate product value in a competitive global marketplace, their Health Economic Research and Quality of Life Evaluation Services (HERQuLES) team was established and became a leader in collecting & analyzing data on the use of healthcare products & services and on their clinical, economic, quality of life, and satisfaction outcomes. In recent years, AACT expanded capabilities to include pricing & reimbursement & marketing consulting and research services, employing a cross-functional matrixed approach ideally suited for their clients' multifaceted needs. In April 2008, AACT was renamed Abt Bio-Pharma Solutions and established as a wholly owned subsidiary of Abt Associates. Their new name reflects the full range of custom services they provide to sponsors globally. The ABS team continues Abt Associates' 40-year history of commitment to providing knowledge, delivering insight, and improving world health.